The iQ Group Global named one of Australia’s Most Innovative Companies for second consecutive year

The iQ Group Global is honoured to be recognised as one of Australia and New Zealand’s Most Innovative Companies for the second year in a row. The prestigious annual list, published by The Australian Financial Review and Boss Magazine, is based on a rigorous assessment process managed by Australia’s leading innovation consultancy, Inventium, in conjunction […]

More

The iQ Group Global collaborates with Harvard University’s Wyss Institute to explore the feasibility of a real-time, printable COVID-19 diagnostic test

The iQ Group Global has entered into a material transfer agreement with Harvard University’s Wyss Institute to explore whether a proprietary technology developed at the Wyss Institute could be used to help provide a printable point-of-care SARS-CoV-2 antibody test for the COVID-19 disease that could produce results in real-time. Life Science Biosensor Diagnostics Pty Ltd […]

More

Explainer: Drug development, the regulatory process and the COVID-19 vaccine race

Athena Kolivos, Chief Scientific Officer CRC & Farmaforce The vaccine discovery and development experience unfolding for COVID-19 serves as a timely reminder that researching, developing and commercialising therapies to prevent, treat or cure life-threatening diseases is an extensive process; one that is very different from bringing everyday products and commodities to the marketplace. Across the […]

More